Roche Czech Republic's net debt stood at CZK 203 mil and accounted for 14.2% of equity at the end of 2016. The ratio is down 41.5 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 113% in 2004 and a low of -10.0% in 2003 between 2003 and 2016. The average for the last five years was 30.8%.
Net debt to EBITDA was calculated at 0.428x at the end of the year. That is up from -0.002x seen in 2011. The ratio reached a high of 4.29x in 2007 and a low of -0.170x in 2003.
The company’s cost of funding amounted to 0.420% in 2016, up which is above the 5-year of -0.146%. Funding costs have “eaten” some 0.514% of the operating profit generated in 2019.
You can see all the company’s data at Roche Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
